A major new scientific review of evidence published in the journal Addiction has identified three top strategies for quitting smoking.
Boehringer seeks approval for lung fibrosis drug following Phase III win
Boehringer’s nerandomilast is a preferential inhibitor of phosphodiesterase 4B (PDE4B). Image credit: Tada Images / Shutterstock. Boehringer Ingelheim is seeking regulatory approval for nerandomilast after